<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39421715</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1411</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>International journal of women's health</Title><ISOAbbreviation>Int J Womens Health</ISOAbbreviation></Journal><ArticleTitle>Health of Saudi Women in the Post-Pandemic Era: <i>Candidiasis</i> Incidence and Post COVID-19 and COVID-19-Vaccination.</ArticleTitle><Pagination><StartPage>1687</StartPage><EndPage>1697</EndPage><MedlinePgn>1687-1697</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJWH.S472953</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Candidiasis, commonly known as yeast infection, affects people worldwide due to the overgrowth of <i>Candida</i> species. Of several types, genital candidiasis, particularly vulvovaginal candidiasis (VVC), primarily caused by <i>C. albicans</i> is frequently observed in females of reproductive age. Candidiasis has also become a serious issue in the post-pandemic era, as it occurs as a secondary infection in COVID-19 patients during or after the course of viral illness. Therefore, this study investigated the incidence of <i>C. albicans</i> infections in women of reproductive age, and its relationship with the incidence of COVID-19 and vaccination in Saudi Arabia.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Additionally, this study aimed to determine the awareness of women on candidiasis and its subsequent impact on the occurrence of infection. A survey-based quantitative study was conducted in which primary data were collected from participants using a self-reported questionnaire.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 200 women aged 18-45 were selected through random sampling. Apart from their sociodemographic characteristics, the history of COVID-19 incidence, COVID-19 vaccination, and candidiasis occurrences among respondents were recorded. Their level of awareness and knowledge of candidiasis, along with their perceptions of strategies for mitigating the risk of incidence, were also evaluated. The collected data were analysed using different statistical tools.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The findings of this study revealed a positive correlation between candidiasis, viral infection, and vaccination, regardless of the type and dosage of vaccine administered. Furthermore, both COVID-19 incidence and vaccination had a positive and significant impact on the occurrence of candidiasis among Saudi women.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Despite certain limitations, this study has theoretical and managerial implications for improved management of candidiasis in the post-COVID era.</AbstractText><CopyrightInformation>© 2024 Alawfi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alawfi</LastName><ForeName>Sami A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0009-0005-8619-1067</Identifier><AffiliationInfo><Affiliation>Clinical Laboratory Sciences Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Womens Health</MedlineTA><NlmUniqueID>101531698</NlmUniqueID><ISSNLinking>1179-1411</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">awareness</Keyword><Keyword MajorTopicYN="N">candidiasis</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword></KeywordList><CoiStatement>The author declares no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39421715</ArticleId><ArticleId IdType="pmc">PMC11484768</ArticleId><ArticleId IdType="doi">10.2147/IJWH.S472953</ArticleId><ArticleId IdType="pii">472953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GKK R, AR P, YV N. Fungal infections: pathogenesis, antifungals and alternate treatment approaches. Curr Res Microb Sci. 2022;3:100137. doi:10.1016/j.crmicr.2022.100137</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crmicr.2022.100137</ArticleId><ArticleId IdType="pmc">PMC9325902</ArticleId><ArticleId IdType="pubmed">35909631</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins N, Ferreira I, Barros L, Silva S, Henriques M. Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment Natália Martins. Mycopathologia. 2014;177(5–6):223–240. doi:10.1007/s11046-014-9749-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11046-014-9749-1</ArticleId><ArticleId IdType="pubmed">24789109</ArticleId></ArticleIdList></Reference><Reference><Citation>Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253–273. doi:10.1128/CMR.00076-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00076-09</ArticleId><ArticleId IdType="pmc">PMC2863365</ArticleId><ArticleId IdType="pubmed">20375352</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabas PS. An approach to etiology, diagnosis and management of different types of candidiasis. J Yeast Fungal Res. 2013;4(6):63–74.</Citation></Reference><Reference><Citation>Meora R, Palande V, Kunchiraman BN. Bacterial Proteins With Anti-Candida Property and Their Mode of Action: a Review. World J Pharm Res. 2015;4(5):615–632.</Citation></Reference><Reference><Citation>Alonso-Monge R, Gresnigt MS, Román E, Hube B, Pla JS. Candida albicans colonization of the gastrointestinal tract: a double-edged sword. PLoS Pathog. 2021;17(7):1–6. doi:10.1371/journal.ppat.1009710</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009710</ArticleId><ArticleId IdType="pmc">PMC8297749</ArticleId><ArticleId IdType="pubmed">34293071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015;373:1445–1456. doi:10.1056/NEJMra1315399</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1315399</ArticleId><ArticleId IdType="pubmed">26444731</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, Camargo LFA, Pignatari ACC, et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49(5):1866–1871. doi:10.1128/JCM.00376-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00376-11</ArticleId><ArticleId IdType="pmc">PMC3122653</ArticleId><ArticleId IdType="pubmed">21411591</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165). doi:10.1126/scitranslmed.3004404</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004404</ArticleId><ArticleId IdType="pubmed">23253612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018;73(suppl_1):i4–13. doi:10.1093/jac/dkx444</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkx444</ArticleId><ArticleId IdType="pubmed">29304207</ArticleId></ArticleIdList></Reference><Reference><Citation>Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339–47. doi:10.1016/S1473-3099(18)30103-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30103-8</ArticleId><ArticleId IdType="pubmed">30078662</ArticleId></ArticleIdList></Reference><Reference><Citation>Losier A, Gupta G, Caldararo M, Dela Cruz CS. The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections. Clin Chest Med. 2023;44(2):407–423. doi:10.1016/j.ccm.2022.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2022.11.018</ArticleId><ArticleId IdType="pmc">PMC9968485</ArticleId><ArticleId IdType="pubmed">37085229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu R, Singla N. COVID-19 and Plethora of Fungal Infections. Curr Fungal Infect Rep. 2022;16(2):47–54. doi:10.1007/s12281-022-00432-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12281-022-00432-2</ArticleId><ArticleId IdType="pmc">PMC8994097</ArticleId><ArticleId IdType="pubmed">35432691</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda VP, Mishra T, Kamaraj S, et al. Post-COVID-19 Fungal Infection in the Aged Population. Vaccines. 2023;11(3):1–26. doi:10.3390/vaccines11030555</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030555</ArticleId><ArticleId IdType="pmc">PMC10056493</ArticleId><ArticleId IdType="pubmed">36992139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasonov E, Samsonov M. The role of Interleukin 6 inhibitors in therapy of severe COVID-19. Biomed Pharmacother. 2020;131:110698. doi:10.1016/j.biopha.2020.110698</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110698</ArticleId><ArticleId IdType="pmc">PMC7455113</ArticleId><ArticleId IdType="pubmed">32920514</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Bilal H, Khan MN, et al. Interleukin inhibitors and the associated risk of candidiasis. Front Immunol. 2024;15:1–10. doi:10.3389/fimmu.2024.1372693</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1372693</ArticleId><ArticleId IdType="pmc">PMC11007146</ArticleId><ArticleId IdType="pubmed">38605952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lass-Flörl C, Steixner S. The changing epidemiology of fungal infections. Mol Aspects Med. 2023;2023:94.</Citation><ArticleIdList><ArticleId IdType="pubmed">37804792</ArticleId></ArticleIdList></Reference><Reference><Citation>Segrelles-Calvo G, GR A, Llopis-Pastor E, et al. Candida spp. co-infection in COVID-19 patients with severe pneumonia: prevalence study and associated risk factors. Respir Med. 2021;188:0–5. doi:10.1016/j.rmed.2021.106619</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106619</ArticleId><ArticleId IdType="pmc">PMC8445759</ArticleId><ArticleId IdType="pubmed">34555702</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CS, Lee SSJ, Chen WC, et al. COVID-19-associated candidiasis and the emerging concern of Candida auris infections. J Microbiol Immunol Infect. 2023;56(4):672–679. doi:10.1016/j.jmii.2022.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9747227</ArticleId><ArticleId IdType="pubmed">36543722</ArticleId></ArticleIdList></Reference><Reference><Citation>Arastehfar A, Carvalho A, Hong Nguyen M, et al. Covid-19-associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions? J Fungi. 2020;6(4):1–13. doi:10.3390/jof6040211</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof6040211</ArticleId><ArticleId IdType="pmc">PMC7712987</ArticleId><ArticleId IdType="pubmed">33050019</ArticleId></ArticleIdList></Reference><Reference><Citation>Routsi C, Meletiadis J, Charitidou E, et al. Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era. Antibiotics. 2022;11(6):1–12. doi:10.3390/antibiotics11060771</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11060771</ArticleId><ArticleId IdType="pmc">PMC9219849</ArticleId><ArticleId IdType="pubmed">35740177</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitriou-Olivgeris M, Spiliopoulou A, Kolonitsiou F, et al. Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009–2017) in a university Greek hospital. Infection. 2019;47(2):209–216. doi:10.1007/s15010-018-1217-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-018-1217-2</ArticleId><ArticleId IdType="pubmed">30196355</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidefond M, Sevestre J, Chaudet H, Ranque S. COVID-19 Is a Confounder of Increased Candida Airway Colonisation. Pathogens. 2023;12(3):1–13. doi:10.3390/pathogens12030463</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12030463</ArticleId><ArticleId IdType="pmc">PMC10052038</ArticleId><ArticleId IdType="pubmed">36986385</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi M, Ahmadikia K, Mahmoudi S, et al. Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: species identification and antifungal susceptibility pattern. Mycoses. 2020;63(8):771–778. doi:10.1111/myc.13137</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.13137</ArticleId><ArticleId IdType="pmc">PMC7361944</ArticleId><ArticleId IdType="pubmed">32609906</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hatmi A, Mohsin J, Al-Huraizi A, Khamis F. COVID-19 associated invasive candidiasis. J Infect. 2021;82(2):e45–6. doi:10.1016/j.jinf.2020.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.005</ArticleId><ArticleId IdType="pmc">PMC7411505</ArticleId><ArticleId IdType="pubmed">32771402</ArticleId></ArticleIdList></Reference><Reference><Citation>Pemán J, Ruiz-Gaitán A, García-Vidal C, et al. Fungal co-infection in COVID-19 patients: should we be concerned? Rev Iberoam Micol. 2020;37(2):41–46. doi:10.1016/j.riam.2020.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.riam.2020.07.001</ArticleId><ArticleId IdType="pmc">PMC7489924</ArticleId><ArticleId IdType="pubmed">33041191</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Boehm A, Sahanic S, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study. Respir Res. 2020;21(1):1–9. doi:10.1186/s12931-020-01546-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01546-2</ArticleId><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed N, Mahmood MS, Ullah MA, et al. COVID-19-Associated Candidiasis: possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies. Curr Microbiol. 2022;79(5):1–15. doi:10.1007/s00284-022-02824-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-022-02824-6</ArticleId><ArticleId IdType="pmc">PMC8918595</ArticleId><ArticleId IdType="pubmed">35287179</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb P, Furceri D, Jimenez D, Kothari S, Ostry JD, Tawk N. Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes. Appl Health Econ Health Pol. 2023;21(1):71–89. doi:10.1007/s40258-022-00757-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40258-022-00757-6</ArticleId><ArticleId IdType="pmc">PMC9470512</ArticleId><ArticleId IdType="pubmed">36100820</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatty AL, Peyser ND, Butcher XE, et al. Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination. JAMA Network Open. 2021;4(12):1–13. doi:10.1001/jamanetworkopen.2021.40364</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.40364</ArticleId><ArticleId IdType="pmc">PMC8696570</ArticleId><ArticleId IdType="pubmed">34935921</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolani P, Pasari A, Bhawane A, Balwani M. COVID ‑ 19 Pneumonitis and Mucormycosis in a COVID‑19 Vaccinated individual. J Nephrol Soc. 2022;1(1):51–53. doi:10.4103/jtns.jtns_16_22</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jtns.jtns_16_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Faidah HS. Vulvovaginal candidiasis among women in Makkah city, Saudi Arabia. Res J Med Sci. 2013;7(4):86–89.</Citation></Reference><Reference><Citation>Al Halteet S, Abdel-hadi A, Hassan M, Awad M. Prevalence and Antifungal Susceptibility Profile of Clinically Relevant Candida Species in Postmenopausal Women with Diabetes. Biomed Res Int. 2020;2020:1–9. doi:10.1155/2020/7042490</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7042490</ArticleId><ArticleId IdType="pmc">PMC7714583</ArticleId><ArticleId IdType="pubmed">33294451</ArticleId></ArticleIdList></Reference><Reference><Citation>Venugopal D, Husain K, Mustafa SA, Sabeen S. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): a study among women in the central region of Saudi Arabia. J Med Mycol. 2021;31(2):1–5. doi:10.1016/j.mycmed.2020.101049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mycmed.2020.101049</ArticleId><ArticleId IdType="pubmed">33153879</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharbi NK, Alghnam S, Algaissi A, et al. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. J Infect Public Health. 2021;14(7):832–838. doi:10.1016/j.jiph.2021.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.04.006</ArticleId><ArticleId IdType="pmc">PMC8188888</ArticleId><ArticleId IdType="pubmed">34118732</ArticleId></ArticleIdList></Reference><Reference><Citation>Algaissi AA, Alharbi NK, Hassanain M, Hashem AM. Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience. J Infect Public Health. 2020;13(6):834–838. doi:10.1016/j.jiph.2020.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.04.016</ArticleId><ArticleId IdType="pmc">PMC7211706</ArticleId><ArticleId IdType="pubmed">32451260</ArticleId></ArticleIdList></Reference><Reference><Citation>Javed N, Zuber M, Amin S, Bugis B, Al-Mohaithef M. COVID-19 cases and deaths after implementation of prevention strategies, Saudi Arabia. East Mediterr Heal J. 2022;28(2):95–107. doi:10.26719/emhj.21.067</Citation><ArticleIdList><ArticleId IdType="doi">10.26719/emhj.21.067</ArticleId><ArticleId IdType="pubmed">35304906</ArticleId></ArticleIdList></Reference><Reference><Citation>Disha T, Haque F. Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: a Review. Infect Dis Obstet Gynecol. 2022;2022. doi:10.1155/2022/6195712</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6195712</ArticleId><ArticleId IdType="pmc">PMC9329029</ArticleId><ArticleId IdType="pubmed">35910510</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrayyes SF, Alruwaili HM, Taher IA, et al. Oral Candidal carriage and associated risk indicators among adults in Sakaka, Saudi Arabia. BMC Oral Health. 2019;19(1):1–7. doi:10.1186/s12903-019-0775-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-019-0775-8</ArticleId><ArticleId IdType="pmc">PMC6530046</ArticleId><ArticleId IdType="pubmed">31117990</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyedjavadi SS, Bagheri P, Nasiri MJ, Razzaghi-Abyaneh M, Goudarzi M. Fungal Infection in Co-infected Patients With COVID-19: an Overview of Case Reports/Case Series and Systematic Review. Front Microbiol. 2022;2022:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9298665</ArticleId><ArticleId IdType="pubmed">35875562</ArticleId></ArticleIdList></Reference><Reference><Citation>Naser R, Al-Mousawi A, Alrubayae I. Prevalence and pathogenicity of non-albicans Candida species among diabetic patients with post infection of Covid-19 in Basrah. HIV Nurs. 2023;23(3):833–838.</Citation></Reference><Reference><Citation>Arastehfar A, Shaban T, Zarrinfar H, et al. Candidemia among Iranian patients with severe COVID-19 admitted to ICUs. J Fungi. 2021;7(4):1–9. doi:10.3390/jof7040280</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof7040280</ArticleId><ArticleId IdType="pmc">PMC8068363</ArticleId><ArticleId IdType="pubmed">33917967</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayant S, Patel K, Priya P, Verma AN, Singh B, Dahariya R. Prevalence of Candida infection in Covid-19 pandemic: a study from a tertiary care center in Central India. Asian J Med Sci. 2021;12(10):3–7. doi:10.3126/ajms.v12i10.38528</Citation><ArticleIdList><ArticleId IdType="doi">10.3126/ajms.v12i10.38528</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathania E, Widjaja JT. Candidiasis as Secondary Infection in Post COVID-19: a New Problem? J Respirasi. 2021;7(3):127. doi:10.20473/jr.v7-I.3.2021.127-133</Citation><ArticleIdList><ArticleId IdType="doi">10.20473/jr.v7-I.3.2021.127-133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamath P, Pais M, Nayak MG, D’souza CP. An Awareness Program on Prevention of Vaginal Candidiasis Among Pregnant Women. J Heal Allied Sci NU. 2014;04(02):086. doi:10.1055/s-0040-1703769</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1703769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>